Xtx Topco LTD Amgen Inc Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Amgen Inc stock. As of the latest transaction made, Xtx Topco LTD holds 5,902 shares of AMGN stock, worth $1.56 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,902

Previous 2,115 179.05%

Holding current value

$1.56 Million

Previous $660,000 188.03%

% of portfolio

0.15%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.17 Million - $1.28 Million	3,787 Added 179.05%	5,902 $1.9 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $555,716 - $675,340	2,115 New	2,115 $660,000
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $15,342 - $17,307	60 Added 6.5%	983 $283,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.72 Million - $2.13 Million	-7,847 Reduced 89.48%	923 $248,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.88 Million - $2.22 Million	8,770 New	8,770 $1.95 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.32 Million - $1.68 Million	5,758 New	5,758 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.3 Million - $2.56 Million	9,956 New	9,956 $2.42 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $322,546 - $356,820	-1,471 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $16,109 - $18,435	-81 Reduced 5.22%	1,471 $331,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $329,443 - $385,982	1,552 New	1,552 $330,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $211,857 - $235,039	-907 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $201,272 - $234,550	907 New	907 $226,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account